KC-1976

HT-29-CLDN18.2-High Cell Line

×
23161
Home » HT-29-CLDN18.2-High Cell Line

Background of HT-29-CLDN18.2-High Cell Line

CLDN18.2 is the isoform 2 of the claudin 18 gene, which belong to the lager claudin family and play the important role in cell tight junction in epithelial cells. CLND18.2 is found overexpressed on gastrointestinal adenocarcinoma and pancreatic tumors. The identification as a tumor target of CLDN18.2 has led to the repaid progress of antibody treatment of gastrointestinal adenocarcinoma and pancreatic tumors, such as IMAB362 (Claudiximab).

Specifications

Catalog NumberKC-1976
Cell Line NameHT-29-CLDN18.2-High Cell Line
NCBI/UniProt Accession NumberNM_001002026.3
Clone Number3#
Host Cell LineHT-29
DescriptionStable HT-29 cell line expressing exogenous human CLDN18.2 gene
QuantityOne vial of frozen cells (≥2×106 cells)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10% FBS +1μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial-like
SubcultureSplit saturated culture 1:4-1:8 every 2-3 days
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 24 hours
Mycoplasma StatusNegative
In Vivo ValidationYes

Cell Line Generation

HT-29-CLDN18.2-High cell line was generated using a lentiviral vector expressing the human CLDN18.2 sequence.

Characterization

Figure 1: Characterization of human CLDN18.2 overexpression in the HT-29-CLDN18.2-High stable clone using FACS.

Figure 2: Tumor growth and body weight curves of NOD SCID nude mice inoculated with HT-29-CLDN18.2-High cells (n=6).

Cell Resuscitation

  1. Pre-warm complete culture medium (RPMI1640+10% FBS +1μg/mL Puromycin) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO2 incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4-1:8 every 2-3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the cell pellet in chilled freezing medium, ensuring a minimum cell density of 3×106 cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

1. Sato M, Ohashi J, Tsuchiya N, Tadokoro K, Juji T, Hanaoka K, et al. (October 2001). Identification of novel single nucleotide substitutions in the NKp30 gene expressed in human natural killer cells. Tissue Antigens. 58 (4): 255–8. doi:10.1034/j.1399-0039.2001.580406.x. PMID 11782277.
2. Barrow AD, Martin CJ, Colonna M (2019-05-07). The Natural Cytotoxicity Receptors in Health and Disease. Frontiers in Immunology. 10: 909. doi:10.3389/fimmu.2019.00909. PMC 6514059. PMID 31134055.
3. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. (November 1999). Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. The Journal of Experimental Medicine. 190 (10): 1505–16.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.